ReviewAntibiotics (Basel, Switzerland)2022

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent

Sahil Khanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.